MGRX vs. SKYW

Last updated Jun 5, 2026

MGRX (Mangoceuticals Inc. Common Stock) and SKYW (SkyWest, Inc.) are both stocks. MGRX operates in Health Information Services (Healthcare), while SKYW operates in Airlines (Industrials). Over the past 3 years, MGRX returned -73.84%/yr vs 35.87%/yr for SKYW. At a 0.10 correlation, their price movements are largely independent.

Performance

MGRX vs. SKYW - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Mangoceuticals Inc. Common Stock (MGRX) and SkyWest, Inc. (SKYW). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, MGRX achieves a -47.39% return, which is significantly lower than SKYW's -16.99% return.

MGRX

• 1D: 3.81%
• 1M: 21.73%
• YTD: -47.39%
• 6M: -67.01%
• 1Y: -82.54%
• 3Y*: -73.84%
• 5Y*: —
• 10Y*: —

SKYW

• 1D: 2.66%
• 1M: 0.16%
• YTD: -16.99%
• 6M: -18.39%
• 1Y: -17.19%
• 3Y*: 35.87%
• 5Y*: 11.66%
• 10Y*: 13.77%

*Multi-year figures are annualized to reflect compound growth (CAGR)

MGRX vs. SKYW - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
MGRX Mangoceuticals Inc. Common Stock	-47.39%	-69.42%	-41.74%	-93.08%
SKYW SkyWest, Inc.	-16.99%	0.28%	91.82%	179.97%

Correlation

The correlation between MGRX and SKYW is 0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.10
Correlation (3Y) Calculated over the trailing 3-year period	0.10
Correlation (All Time) Calculated using the full available price history since Mar 22, 2023	0.10

Fundamentals

Market Cap MGRX : $3.92M SKYW : $3.39B
EPS MGRX : -$1.96 SKYW : $10.42
PS Ratio MGRX : 13.44 SKYW : 0.83
Total Revenue (TTM) MGRX : $304.81K SKYW : $4.12B
Gross Profit (TTM) MGRX : $250.39K SKYW : $1.73B
EBITDA (TTM) MGRX : -$18.03M SKYW : $970.77M

Return for Risk

MGRX vs. SKYW — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MGRX

MGRX Risk / Return Rank: 18
MGRX Sharpe Ratio Rank: 22
MGRX Sortino Ratio Rank: 27
MGRX Omega Ratio Rank: 27
MGRX Calmar Ratio Rank: 7
MGRX Martin Ratio Rank: 9

SKYW

SKYW Risk / Return Rank: 22
SKYW Sharpe Ratio Rank: 21
SKYW Sortino Ratio Rank: 20
SKYW Omega Ratio Rank: 21
SKYW Calmar Ratio Rank: 25
SKYW Martin Ratio Rank: 24

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MGRX vs. SKYW - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Mangoceuticals Inc. Common Stock (MGRX) and SkyWest, Inc. (SKYW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	MGRX	SKYW	Difference
Sharpe ratio: Return per unit of total volatility	-0.45	-0.48	+0.03
Sortino ratio: Return per unit of downside risk	-0.13	-0.48	+0.36
Omega ratio: Gain probability vs. loss probability	0.98	0.95	+0.04
Calmar ratio: Return relative to maximum drawdown	-0.88	-0.47	-0.41
Martin ratio: Return relative to average drawdown	-1.38	-0.89	-0.48
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

MGRX vs. SKYW - Sharpe Ratio Comparison

The current MGRX Sharpe Ratio is -0.45, which is comparable to the SKYW Sharpe Ratio of -0.48. The chart below compares the historical Sharpe Ratios of MGRX and SKYW, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	MGRX	SKYW	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.45	-0.48	+0.03
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.27	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.27	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.48	0.24	-0.73

Drawdowns

MGRX vs. SKYW - Drawdown Comparison

The maximum MGRX drawdown since its inception was -99.73%, which is greater than SKYW's maximum drawdown of -81.77%. Use the drawdown chart below to compare losses from any high point for MGRX and SKYW.

Drawdown Indicators

	MGRX	SKYW	Difference
Max Drawdown Largest peak-to-trough decline	-99.73%	-81.77%	-17.96%
Max Drawdown (1Y) Largest decline over 1 year	-94.09%	-36.63%	-57.46%
Max Drawdown (3Y) Largest decline over 3 years	-99.43%	-36.63%	-62.80%
Max Drawdown (5Y) Largest decline over 5 years	—	-71.50%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-81.77%	—
Current Drawdown Current decline from peak	-99.35%	-32.63%	-66.72%
Average Drawdown Average peak-to-trough decline	-90.00%	-35.43%	-54.57%
Ulcer Index Depth and duration of drawdowns from previous peaks	60.39%	19.31%	+41.08%

Volatility

MGRX vs. SKYW - Volatility Comparison

Mangoceuticals Inc. Common Stock (MGRX) has a higher volatility of 45.81% compared to SkyWest, Inc. (SKYW) at 12.09%. This indicates that MGRX's price experiences larger fluctuations and is considered to be riskier than SKYW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	MGRX	SKYW	Difference
Volatility (1M) Calculated over the trailing 1-month period	45.81%	12.09%	+33.72%
Volatility (6M) Calculated over the trailing 6-month period	159.08%	27.06%	+132.02%
Volatility (1Y) Calculated over the trailing 1-year period	183.85%	36.42%	+147.43%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	164.00%	43.55%	+120.45%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	164.00%	51.45%	+112.55%

Dividends

MGRX vs. SKYW - Dividend Comparison

Neither MGRX nor SKYW has paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
MGRX Mangoceuticals Inc. Common Stock	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SKYW SkyWest, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.35%	0.74%	0.90%	0.60%	0.52%	0.84%

Financials

Frequently Asked Questions

Can I hold both MGRX and SKYW in my portfolio?

MGRX and SKYW have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, MGRX or SKYW?

MGRX has higher volatility (45.81%) compared to SKYW (12.09%). In terms of maximum drawdown, MGRX dropped -99.73% vs SKYW's -81.77%.

Which has better risk-adjusted returns?

MGRX currently has the higher Sharpe Ratio (-0.45 vs -0.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.